{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:54:16Z","timestamp":1754398456269},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T00:00:00Z","timestamp":1373587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10792-013-9823-6","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T11:11:30Z","timestamp":1373541090000},"page":"241-249","source":"Crossref","is-referenced-by-count":5,"title":["Topical glaucoma therapy cost in Mexico"],"prefix":"10.1007","volume":"34","author":[{"given":"Gabriel","family":"Lazcano-Gomez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Hernandez-Oteyza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Iriarte-Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Hernandez-Garciadiego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,12]]},"reference":[{"issue":"3","key":"9823_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262\u2013267","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"9823_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajo.2011.06.004","volume":"152","author":"R Varma","year":"2011","unstructured":"Varma R, Lee PP, Goldberg I, Kotak S (2011) An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol 152(4):515\u2013522","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"9823_CR3","first-page":"3393","volume":"43","author":"AT Broman","year":"2002","unstructured":"Broman AT, Mu\u00f1oz B, Rodriguez J, Sanchez R, Quigley HA, Klein R et al (2002) The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci 43(11):3393\u20133398","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"9823_CR4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ajo.2007.02.022","volume":"143","author":"R McKean-Cowdin","year":"2007","unstructured":"McKean-Cowdin R, Varma R, Wu J et al (2007) Severity of visual field loss and health-related quality of life. Am J Ophthalmol 143(6):1013\u20131023","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"9823_CR5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","volume":"115","author":"R McKean-Cowdin","year":"2008","unstructured":"McKean-Cowdin R, Wang Y, Wu J et al (2008) Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology 115(6):941\u2013948","journal-title":"Ophthalmology"},{"key":"9823_CR6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ophtha.2008.12.056","volume":"116","author":"DB Rein","year":"2009","unstructured":"Rein DB, Wittenborn JS, Lee PP et al (2009) The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Ophthalmology 116:823\u2013833","journal-title":"Ophthalmology"},{"issue":"12","key":"9823_CR7","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","volume":"124","author":"DB Rein","year":"2006","unstructured":"Rein DB, Zhang P, Wirth KE et al (2006) The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 124(12):1754\u20131760","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"9823_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.124.1.12","volume":"124","author":"PP Lee","year":"2006","unstructured":"Lee PP, Walt JG, Doyle JJ et al (2006) A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 124(1):12\u201319","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"9823_CR9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2005.067355","volume":"89","author":"CE Traverso","year":"2005","unstructured":"Traverso CE, Walt JG, Kelly SP et al (2005) Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 89(1):1245\u20131249","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"9823_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ijg.0000212250.95078.6f","volume":"15","author":"DK Gieser","year":"2006","unstructured":"Gieser DK, Tracy Williams R, O\u2019Connell W, Pasquale LR, Rosenthal BP, Walt JG et al (2006) Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study. J Glaucoma 15(5):419\u2013425","journal-title":"J Glaucoma"},{"issue":"1","key":"9823_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1755-3768.2011.02212.x","volume":"91","author":"J Olsen","year":"2013","unstructured":"Olsen J, Berdeaux G, Skov J (2013) Glaucoma costs in Denmark in treatment naive patients. Acta Ophthalmol 91(1):25\u201331","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"9823_CR12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0420.2005.00560.x","volume":"84","author":"B Lindblom","year":"2006","unstructured":"Lindblom B, Nordmann JP, Sellem E et al (2006) A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden. Acta Ophthalmol Scand 84(7):74\u201383","journal-title":"Acta Ophthalmol Scand"},{"key":"9823_CR13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","volume":"116","author":"JC Tsai","year":"2009","unstructured":"Tsai JC (2009) A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology 116:S30\u2013S36","journal-title":"Ophthalmology"},{"key":"9823_CR14","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2147\/OPTH.S37145","volume":"6","author":"AO Adio","year":"2012","unstructured":"Adio AO, Onua AA (2012) Economic burden of glaucoma in Rivers State, Nigeria. Clin Ophthalmol 6:2023\u20132031","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"9823_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0004-27492005000100014","volume":"68","author":"IG Stillitano","year":"2005","unstructured":"Stillitano IG, Lima MG, Ribeiro MP, Cabral J, Brandt CT (2005) Economic impact of eyedrop cost in glaucoma treatment. Arq Bras Oftalmol 68(1):79\u201384","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"9823_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1248\/yakushi.125.463","volume":"125","author":"H Ikeda","year":"2005","unstructured":"Ikeda H, Tsukamoto H, Sawa A, Sugimoto A, Mishima H, Kihira K (2005) Comparison of annual cost between Brand and generic ocular beta-adrenergic blockers. Yakugaku Zasshi 125(5):463\u2013467","journal-title":"Yakugaku Zasshi"},{"issue":"4","key":"9823_CR17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9394(99)00235-4","volume":"128","author":"RG Fiscella","year":"1999","unstructured":"Fiscella RG, Geller JL, Gryz LL, Wilensky J, Viana M (1999) Cost considerations of medical therapy for glaucoma. Am J Ophthalmol 128(4):426\u2013433","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"9823_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9394(03)00102-8","volume":"136","author":"RG Fiscella","year":"2003","unstructured":"Fiscella RG, Green A, Patuszynski DH, Wilensky J (2003) Medical therapy cost considerations for glaucoma. Am J Ophthalmol 136(1):18\u201325","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"9823_CR19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/IJG.0b013e318064c818","volume":"16","author":"Y Gao","year":"2007","unstructured":"Gao Y, Wu L, Li A (2007) Daily cost of glaucoma medications in China. J Glaucoma 16(7):594\u2013597","journal-title":"J Glaucoma"},{"issue":"1","key":"9823_CR20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2007.08.041","volume":"145","author":"NR Rylander","year":"2008","unstructured":"Rylander NR, Vold SD (2008) Cost analysis of glaucoma medications. Am J Ophthalmol 145(1):106\u2013113","journal-title":"Am J Ophthalmol"},{"key":"9823_CR21","unstructured":"IMS Health. [Online]. HYPERLINK http:\/\/www.imshealth.com"},{"key":"9823_CR22","unstructured":"Diario Oficial de la Federaci\u00f3n. [Online]. HYPERLINK http:\/\/dof.gob.mx\/indicadores.php"},{"issue":"4","key":"9823_CR23","first-page":"232","volume":"5","author":"AE Omoti","year":"2010","unstructured":"Omoti AE, Edema OT, Akpe BA, Musa P (2010) Cost analysis of medical versus surgical management of glaucoma in Nigeria. J Ophthalmic Vis Res 5(4):232\u2013239","journal-title":"J Ophthalmic Vis Res"},{"key":"9823_CR24","first-page":"7","volume":"27","author":"RE Frenkel","year":"2007","unstructured":"Frenkel RE, Frenkel M, Toler A (2007) Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension. BMC Ophthalmol 27:7\u201316","journal-title":"BMC Ophthalmol"},{"key":"9823_CR25","unstructured":"US Inflation Calculator. [Online]. HYPERLINK http:\/\/www.usinflationcalculator.com\/inflation\/current-inflation-rates\/ . Accessed April 2013"},{"key":"9823_CR26","unstructured":"Banco de M\u00e9xico. [Online]. HYPERLINK http:\/\/www.banxico.org.mx\/portal-inflacion\/ . Accessed April 2013"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-013-9823-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-013-9823-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-013-9823-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T10:59:17Z","timestamp":1715684357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-013-9823-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,12]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["9823"],"URL":"https:\/\/doi.org\/10.1007\/s10792-013-9823-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,12]]}}}